| 2026-07-20 |
SCHEDULE 13G |
Research Alliance Corp IV |
— |
— |
view → |
| 2026-07-16 |
SCHEDULE 13D/A |
XOMA Royalty Corp |
— |
0 |
view → |
| 2026-07-10 |
SCHEDULE 13G |
Pyxis Oncology, Inc. PYXS |
— |
— |
view → |
| 2026-06-29 |
SCHEDULE 13D/A |
MoonLake Immunotherapeutics MLTX |
19.70% |
8,302,735 |
view → |
| 2026-06-26 |
SCHEDULE 13D/A |
Kymera Therapeutics, Inc. KYMR |
6.30% |
2,712,852 |
view → |
| 2026-06-04 |
SCHEDULE 13G |
Q32 Bio Inc. QTTB |
— |
— |
view → |
| 2026-05-29 |
SCHEDULE 13G |
Research Alliance Corp III RACC |
— |
— |
view → |
| 2026-05-27 |
SCHEDULE 13G |
OnKure Therapeutics, Inc. OKUR |
— |
— |
view → |
| 2026-05-18 |
SCHEDULE 13D/A |
XOMA Royalty Corp XOMAP |
— |
3,635,758 |
view → |
| 2026-04-02 |
SCHEDULE 13D/A |
MoonLake Immunotherapeutics MLTX |
22.30% |
8,302,735 |
view → |
| 2025-11-24 |
SCHEDULE |
Repare Therapeutics Inc. |
24.00% |
10,333,600 |
view → |
| 2025-05-20 |
SCHEDULE |
XOMA Royalty Corp XOMAP |
21.60% |
2,590,303 |
view → |
| 2025-01-28 |
SCHEDULE |
XOMA Royalty Corp XOMAP |
25.30% |
2,983,026 |
view → |
| 2024-10-08 |
SC |
MoonLake Immunotherapeutics MLTX |
— |
— |
view → |
| 2024-07-19 |
SC |
Inventiva S.A. IVEVF |
— |
— |
view → |
| 2024-01-29 |
SC |
Rain Oncology Inc. |
— |
— |
view → |
| 2024-01-09 |
SC |
Kymera Therapeutics, Inc. KYMR |
— |
— |
view → |
| 2023-12-18 |
SC |
Rain Oncology Inc. |
— |
— |
view → |
| 2023-06-30 |
SC |
MoonLake Immunotherapeutics MLTX |
— |
— |
view → |
| 2021-09-15 |
SC |
Rain Therapeutics Inc. |
— |
— |
view → |